Noninvasix, Inc. — Form D/A
Noninvasix, Inc. of GALVESTON, TX, a company, filed a Form D amendment with the SEC on 2020-06-11. The offering totals $4.0M, of which $4.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2020-06-11
- Form: D/A
- Accession: 0001808205-20-000003
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $4.0M
- Remaining: $3K
- Investors: 18
- Date of first sale: 2020-03-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-364094
Issuer
- Name: Noninvasix, Inc.
- CIK: 0001808205
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: C/O UNIVERSITY OF TX MEDICAL BRANCH, GALVESTON, TX, 77555
- Phone: 409-772-2965
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Michael S Lowe | Director | Galveston, TX |
| Thomas S Luby | Director | Galveston, TX |
| Donald S Prough | Director | Galveston, TX |
| Graham L Randall | Director | Galveston, TX |
| Donald S Prough | Executive Officer | Galveston, TX |
| Graham L Randall | Executive Officer | Galveston, TX |
Other filings by this issuer (1)
More